FDA and Industry Prepare for End to COVID-19 Emergency.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Abstract:
      The article discusses the implications of the termination of the public health emergency declared in March 2020 in the U.S. Topics include the impact on the U.S. Food and Drug Administration (FDA) policies governing the approval and marketing of drugs and medical products, telehealth services, and the reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA).